12 February 2024

GSK Stockmann contributed to the publication of the Chambers Global Practice Guide – Securitisation

The new edition of the Global Practice Guide – Securitisation has been published by Chambers.

The Securitisation 2024 guide features over 20 jurisdictions and covers the latest developments in insolvency laws, special-purpose entities, the construction of bankruptcy-remote transactions, taxes and tax avoidance, accounting rules, disclosure laws or regulations, credit risk retention, rating agencies, the use of derivatives and synthetic securitisation.

The guide contains two sections: The “Law & Practice” section provides easily accessible information on navigating the legal system when conducting business in the jurisdiction. Leading lawyers explain local law and practice at key transactional stages and for crucial aspects of doing business. The “Trends & Developments” section gives an overview of current trends and developments in local legal markets. Leading lawyers analyse particular trends or provide a broader discussion of key developments in the jurisdiction.

GSK Stockmann contributed to the guide’s publication: Andreas Heinzmann (Partner at GSK Stockmann in Luxembourg), Dr. Manuel Fernandez (Partner at GSK Stockmann in Luxembourg), Valerio Scollo (Partner at GSK Stockmann in Luxembourg) and Katharina Schramm (Senior Associate at GSK Stockmann in Luxembourg) composed the section “Securitisation – Luxembourg Trends & Developments”.

This chapter was originally published in the Chambers Global Practice Guide – Securitisation and is available for download as a PDF file; the whole guide is free to access as eGuide and on the Chambers website.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
  • 11.09.2023

    GSK Update: Application of the law on a national screening mechanism for foreign direct investments in Luxembourg

    Read more
Contact person

Andreas Heinzmann, LL.M. eur.

Partner

+352 271802-30

andreas.heinzmann@gsk-lux.com

Dr. Manuel Fernandez

Partner

+352 271802-31

manuel.fernandez@gsk-lux.com

Valerio Scollo, LL.M. (NYU), LL.M. (NUS)

Partner

+352 271802-32

valerio.scollo@gsk-lux.com

Katharina Schramm

Senior Associate

+352 271802-34

katharina.schramm@gsk-lux.com

© GSK Stockmann 2024